MOHFW

IISc start-up gets regulatory approvals for COVID-19 test

IISc start-up gets regulatory approvals for COVID-19 test

New Delhi: PathShodh Healthcare, a start-up incubated at the Society for Innovation and Development (SID), Indian Institute of Science (IISc), has made a significant breakthrough in developing a first-of-its-kind, semi-quantitative electrochemical ELISA test for COVID-19 IgM and IgG antibodies. PathShodh has received the license to manufacture the test for sale from the Central Drugs Standard Control Organisation (CDSCO), after due diligence validation at the Translational Health Science and Technology Institute (THSTI), Faridabad, as per the requirements of the Indian Council of Medical Research (ICMR). The novelty of the technology is based on the measurement of electrochemical redox activity of IgM…
Read More
Good news amidst the nationwide Oxygen shortage

Good news amidst the nationwide Oxygen shortage

New Delhi:  The nation is reeling under an unprecedented wave of COVID-19 infections. India’s number of COVID infections reported in a single day has surpassed the previous highest one-day rise in the world reported by the United States in January 2021. COVID-19 affects different people in different ways. Most infected people develop mild to moderate illness and recover without hospitalization. Severe illness caused by coronavirus calls for oxygen therapy. Currently, there is a massive short supply of medical-grade oxygen across the country. CSIR-CMERI (Council of scientific and industrial research- Central mechanical engineering research institute) has developed a new Oxygen enrichment…
Read More